Aerpio Pharmaceuticals, Inc. (ARPO): Price and Financial Metrics
ARPO Price/Volume Stats
| Current price | $2.20 | 52-week high | $3.32 |
| Prev. close | $2.22 | 52-week low | $0.95 |
| Day low | $2.16 | Volume | 826,000 |
| Day high | $2.30 | Avg. volume | 5,147,753 |
| 50-day MA | $2.04 | Dividend yield | N/A |
| 200-day MA | $1.64 | Market Cap | 104.85M |
ARPO Stock Price Chart Interactive Chart >
Aerpio Pharmaceuticals, Inc. (ARPO) Company Bio
Aerpio Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for ocular diseases. The company's lead product candidate is AKB-9778, a small molecule activator of the Tie2 pathway, which completed the Phase 2a clinical trial for the treatment of diabetic retinopathy. It also develops ARP-1536, a humanized monoclonal antibody that is in preclinical development stage for the treatment of diabetic vascular complications; and AKB-4924, a selective stabilizer of hypoxia-inducible factor-1 alpha, which has completed a single ascending dose clinical trial for the treatment of inflammatory bowel disease. The company is based in Cincinnati, Ohio
ARPO Latest News Stream
| Event/Time | News Detail | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ARPO Price Returns
| 1-mo | N/A |
| 3-mo | N/A |
| 6-mo | N/A |
| 1-year | N/A |
| 3-year | N/A |
| 5-year | 91.30% |
| YTD | N/A |
| 2024 | N/A |
| 2023 | N/A |
| 2022 | N/A |
| 2021 | 0.00% |
| 2020 | 57.18% |